Botulinum Toxin Injection with Conjunctival Microincision for the Treatment of Acute Acquired Comitant Esotropia and Its Effectiveness

Table 5

Post-BTXA 6 months and Post-BTXA at final follow-up comparison in patients with AACE.

		Post-BTXA 6 months	Post-BTXA at final follow-up
Angle of deviation (PD)	Near	0.62 ± 4.1	1.7 ± 6.8	0.259
	Distance	3.0 ± 5.9	3.9 ± 7.1	0.326

BTXA: botulinum toxin A, PD: prism diopters.